|
|
Advertisement
|
|
Register Today for the NEXT Summit
Registration is officially open for the NEXT Summit: Novel Explorations in Combination Therapies, taking place in Chicago, 5-6 June 2025. This in-person, multidisciplinary event is being hosted in partnership with both the International Liver Cancer Association (ILCA) and the Society for Immunotherapy of Cancer (SITC).
Join physicians, industry members, and multidisciplinary partners for the opportunity to explore future directions in immunotherapies and combination therapy treatments, presented through a multi-society collaboration with expert lectures, hands-on training, and industry connections. This is a unique opportunity to have direct conversations with medical oncologists, researchers, and multidisciplinary team (MDT) partners in immuno-oncology about the role of interventional care in combination therapies.
By registering for the NEXT Summit, attendees unlock complimentary access to SITC's Advances in Cancer Immunotherapy (ACI) program as well as ILCA's Single Topic Workshop: Emerging Role of Y90.
As an additional incentive, practicing physicians can add an MDT partner for free when they register.
Secure your front row seat to in-depth, expert-led discussions on emerging data, best practices, challenges, and case examples.
Register Now
|
Advertisement
|
One Month Left to Apply: SIO Research Grants on Lipiodol and Immunotherapy
Planning to submit an application for the open grants call? Now is the time! SIO, in collaboration with Guerbet, is seeking research proposals on Lipiodol-mediated locoregional delivery of immunotherapeutics. This is your opportunity to drive innovation in interventional oncology and advance the use of Lipiodol as a carrier for locoregional, image-guided immunotherapy delivery to solid tumors.
View the eligibility requirements and learn more about the application procedures by visiting the SIO website. The deadline to submit your proposal is 7 April 2025. Grant recipients will be selected in Spring 2025.
Learn More
|
Register Now for Upcoming Webinars
From management of RCC to emerging trends for lung treatment, SIO has your educational needs covered with these upcoming webinars! Don't miss the chance to expand your knowledge and stay ahead in the rapidly evolving field of oncology.
Tuesday, 18 March - SIO Guidelines for Percutaneous T1B and Endophytic RCC with Combination of Renal Artery Embolization, 7 p.m. ET
Wednesday, 21 May - SIO Emerging Trends in Lung, 7 p.m. ET
Tuesday, 10 June - Percutaneous Ablation of Non-Renal Tumors, 6:30 p.m. ET
Register Now
|
Advertisement
|
2025 Membership is Waiting for You — Rejoin Here!
If you forgot to renew your membership for 2025, now is the time to rejoin! Don't miss out on valuable membership benefits—rejoin today to continue enjoying all the perks and opportunities SIO has to offer.
Unsure which membership you qualify for?
View our membership descriptions here to find the one that's right for you. If you're still unsure, feel free to email us at info@sio-central.org
If you're having trouble signing into your SIO account, follow these instructions to verify your email and activate your SIO portal account:
- Select "login" in the upper right corner of the SIO website
- Select "Set Up an Account."
- Enter your name and email address on record with SIO.
- Enter a new password.
- You will receive a "Verify your email" message to your inbox. Click the link to verify.
- A welcome message from SIO will be sent to your inbox to access your new SIO Portal.
- If you're having trouble finding the email, we recommend searching for "SIO" in your inbox.
Reactivate Your Membership
Hassle-Free Renewal! Choose our auto-renew option and never worry about your membership expiring. Just set it and forget it.
|
Advertisement
|
Advertisement
|
Promoted by Medtronic
Outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation System from the OPuS One trial were recently published in the November edition of the Journal of Vascular and Interventional Radiology (JVIR). Learn more about the largest prospective study in radiofrequency ablation for bone metastases. Read More
|
|
IO Insights
The Society of Interventional Oncology
2001 K Street NW, 3rd Floor North | Washington, DC 20006 USA
202-367-1164 | Contact Us
www.sio-central.org
|
|
|
|
|
|